CADL Competitors & Alternatives
Compare Candel Therapeutics Inc with similar stocks in the same industry
Biotechnology
CADL
Main Stock$8.77
Tradestie Score
61
Market Cap
$304.12M
Analyst Upside
+115.2%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$37.04
|
$715.25M | - | 57 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$114.24
|
$699.30M | - | 60 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.55
|
$688.47M | - | 45 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$9.08
|
$670.30M | - | 45 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.40
|
$665.30M | - | 55 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$10.23
|
$626.91M | - | 50 | Compare |
|
SVRA
Savara Inc.
|
$5.03
|
$611.84M | - | 57 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$26.73
|
$608.81M | - | 62 | Compare |
More CADL Analysis
Data updated: May 16, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry